Last edition
News about "Experimental Medicine"
National Institute for Health and Care Research launches a nationwide collaboration to accelerate Parkinson’s research, bringing together academia, NHS and charities to drive faster development of treatments and diagnostics.
Experimental Medicine | 27/04/2026 | By News Bureau
Boehringer Ingelheim Begins Phase IIa Trial of BI 765423 in IPF
Boehringer Ingelheim has initiated a Phase IIa clinical trial of BI 765423, a novel IL-11–targeting monoclonal antibody, in patients with Idiopathic Pulmonary Fibrosis (IPF), advancing its efforts to develop new treatment options for progressive fibrotic lung diseases.
Experimental Medicine | 15/01/2026 | By News Bureau | 590
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy